Acute Stroke: Shifting From Informed Consent to Informed Refusal of Intravenous Tissue-Type Plasminogen Activator.
نویسنده
چکیده
Relationship Between Physician and Hospital Procedure Volume and Mortality After Carotid Artery Stenting Among Medicare Beneficiaries Jessica J. Jalbert, PhD; Marie D. Gerhard-Herman, MD; Louis L. Nguyen, MD, MBA, MPH; Michael R. Jaff, DO; Hiraku Kumamaru, MD, MPH, ScD; Lauren A. Williams, BA; Chih-Ying Chen, PhD; Jun Liu, MD, MPH; John D. Seeger, PharmD, DrPH; Andrew T. Rothman, MSc; Peter Schneider, MD; Thomas G. Brott, MD; Thomas T. Tsai, MD, MSc; Herbert D. Aronow, MD, MPH; Joseph A. Johnston, MD, MSc; Soko Setoguchi, MD, DrPH · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · S81
منابع مشابه
Pilot Randomized Trial of Tissue Plasminogen Activator in Acute Ischemic Stroke
Background and Purpose: Early thrombolytic therapy with recombinant tissue-type plasminogen activator is a theoretically attractive approach to the treatment of acute focal cerebral ischemia. In preparation for a larger multicenter trial, three centers piloted a protocol for a randomized, double-blind, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator begun w...
متن کاملPilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group.
BACKGROUND AND PURPOSE Early thrombolytic therapy with recombinant tissue-type plasminogen activator is a theoretically attractive approach to the treatment of acute focal cerebral ischemia. In preparation for a larger multicenter trial, three centers piloted a protocol for a randomized, double-blind, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator begun wi...
متن کاملVariability in the Perception of Informed Consent for IV-tPA during Telestroke Consultation
OBJECTIVE To study the perception of informed consent among various raters for thrombolysis in acute ischemic stroke patients receiving intravenous tissue plasminogen activator (IV-tPA). METHODS Twenty randomly selected videotaped telestroke consultations of acute stroke patients administered IV-tPA were retrospectively reviewed. Adequacy of informed consent was reviewed by five raters: a neu...
متن کاملConsent for intravenous thrombolysis in acute stroke: review and future directions.
Intravenous thrombolysis with recombinant tissue plasminogen activator is the standard of care for the treatment of acute ischemic stroke within 3 hours after stroke onset. Randomized clinical studies have demonstrated that intravenous thrombolysis improves functional outcomes but is not lifesaving. Complications of intravenous thrombolysis include severe intracranial hemorrhage that may be let...
متن کاملA clinical study investigating the three months prognosis of patients with ischemic stroke treated with recombinant tissue plasminogen activator (rt-PA) and its effective factors
Objective: Currently, treating ischemic stroke by intravenous thrombolytic therapy has acceptable results in patients with stroke. This study aimed to evaluate the three months prognosis of patients treated with recombinant tissue plasminogen activator (rt-PA).Methods: This cross-sectional prospective study was conducted on 30 patients with cerebral ischemic stroke with the National Insti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Circulation. Cardiovascular quality and outcomes
دوره 8 6 Suppl 3 شماره
صفحات -
تاریخ انتشار 2015